Sulfoxyphenylpyrazolidine en es it fr

Sulfoxyphenylpyrazolidine Brand names, Sulfoxyphenylpyrazolidine Analogs

Sulfoxyphenylpyrazolidine Brand Names Mixture

  • No information avaliable

Sulfoxyphenylpyrazolidine Chemical_Formula


Sulfoxyphenylpyrazolidine RX_link

Sulfoxyphenylpyrazolidine fda sheet

Sulfoxyphenylpyrazolidine msds (material safety sheet)

Sulfoxyphenylpyrazolidine Synthesis Reference

No information avaliable

Sulfoxyphenylpyrazolidine Molecular Weight

404.483 g/mol

Sulfoxyphenylpyrazolidine Melting Point

136-137 oC

Sulfoxyphenylpyrazolidine H2O Solubility

31.2 mg/L

Sulfoxyphenylpyrazolidine State


Sulfoxyphenylpyrazolidine LogP


Sulfoxyphenylpyrazolidine Dosage Forms

100-mg tablets and 200-mg capsules for oral administration

Sulfoxyphenylpyrazolidine Indication

For the treatment of gout and gouty arthritis.

Sulfoxyphenylpyrazolidine Pharmacology

Sulfinpyrazone's pharmacologic activity is the potentiation of the urinary excretion of uric acid. It is useful for reducing the blood urate levels in patients with chronic tophaceous gout and acute intermittent gout, and for promoting the resorption of tophi.

Sulfoxyphenylpyrazolidine Absorption

No information avaliable

Sulfoxyphenylpyrazolidine side effects and Toxicity

Symptoms of overdose include nausea, vomiting, diarrhea, epigastric pain, ataxia, labored respiration, convulsions, coma. Possible symptoms, seen after overdosage with other pyrazolone derivatives: anemia, jaundice, and ulceration.

Sulfoxyphenylpyrazolidine Patient Information

No information avaliable

Sulfoxyphenylpyrazolidine Organisms Affected

Humans and other mammals